John Spohn Achieves CPIP Credential

Print this page         

ISPE invites your comments on FDA's Amendments to Sterility Test Requirements for Biological Products

The Food and Drug Administration (FDA) proposes to amend the sterility test requirements for biological products. This proposed rule is intended to provide manufacturers of biological products greater flexibility and to encourage use of the most appropriate and state-of-the-art test methods for assuring the safety of biological products.

ISPE will be collecting comments for the proposed amendments from interested members. Please submit comments to biosterility@ispe.org by 25 August 2011.

My ISPE

  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile

ISPEAK Logo

An ISPE
Information
Resource

Design Considerations for WFI Distillation Systems Part 2
Thursday, 28 Apr 2016 18.04

2016 Annual Meeting Honorary Chair, Joseph Jimenez, Novartis
Tuesday, 26 Apr 2016 12.04

Pharmaceutical Training to Meet Your Needs
Friday, 22 Apr 2016 16.04